NCT04353206View on ClinicalTrials.gov

Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure

EARLY_PHASE1TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 27, 2020

Primary Completion Date

November 1, 2020

Study Completion Date

November 1, 2020

Conditions
Covid-19Sars-CoV2
Interventions
BIOLOGICAL

Multiple Doses of Anti-SARS-CoV-2 convalescent plasma

Subjects to receive single or double plasma units infused on day 0 and potentially days 3 and 6.

Trial Locations (2)

21287

Johns Hopkins University, Baltimore

90048

8700 Beverly Blvd., Los Angeles

Sponsors

Lead Sponsor

Noah Merin
All Listed Sponsors
collaborator

Johns Hopkins University

OTHER

lead

Noah Merin

OTHER

NCT04353206 - Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure | Biotech Hunter | Biotech Hunter